These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Hematologic complications in antiepileptic therapy]. Fedotov DD; Shapiro IuL; Vaĭntrub MIa Zh Nevropatol Psikhiatr Im S S Korsakova; 1968; 67(8):1239-46. PubMed ID: 4878530 [No Abstract] [Full Text] [Related]
4. [Clinical manifestations of the complications of anticonvulsant chemotherapy. (General review)]. Popescu F Neurol Psihiatr Neurochir; 1968; 13(3):243-54. PubMed ID: 5696339 [No Abstract] [Full Text] [Related]
5. [Benzene and the early recognition of its blood-damaging effects]. MERKER H Med Klin; 1962 Jul; 57():1254-62. PubMed ID: 14472826 [No Abstract] [Full Text] [Related]
6. Chloramphenicol therapy: a warning. KRIEGER E Can Med Assoc J; 1961 Mar; 84(10):550-1. PubMed ID: 13754329 [No Abstract] [Full Text] [Related]
8. Blood changes in workers after chronic exposure to mercaptophos. YUSHKEVICH LB Probl Gematol Pereliv Krovi; 1961; 6():467-9. PubMed ID: 14040390 [No Abstract] [Full Text] [Related]
9. HAEMATOLOGICAL ASPECTS DURING TREATMENT WITH ANTICONVULSANT DRUGS. DE VRIES SI Epilepsia; 1965 Mar; 6():1-15. PubMed ID: 14302044 [No Abstract] [Full Text] [Related]
10. [Pathogenic considerations on megaloblastosis caused by anticonvulsants in relation to folic acid and pyrimidine nucleotides]. PASQUARIELLO G Acta Vitaminol; 1960 Oct; 14():211-22. PubMed ID: 13733149 [No Abstract] [Full Text] [Related]
11. Blood dyscrasias associated with tolbutamide therapy. BROD RC J Am Med Assoc; 1959 Sep; 171():296-7. PubMed ID: 13804609 [No Abstract] [Full Text] [Related]
12. [The value of certain hematological changes for the determination of nitrobenzene toxicity]. LONDON M; SERBAN P; POPOVICI C Arch Mal Prof; 1960; 21():205-10. PubMed ID: 14418095 [No Abstract] [Full Text] [Related]
13. [Blood diseases caused by drugs]. STICH W Blut; 1961 Nov; 7():321-4. PubMed ID: 13917186 [No Abstract] [Full Text] [Related]
14. [Blood and bone marrow damage caused by drugs]. Lüdin H Schweiz Med Wochenschr; 1965 Jul; 95(31):1027-32. PubMed ID: 5319589 [No Abstract] [Full Text] [Related]
15. [Nephrotic syndrome due to epidione treatment]. PIERSON M; LASCOMBES G; VERT P Arch Fr Pediatr; 1959; 16():1389-94. PubMed ID: 14432875 [No Abstract] [Full Text] [Related]
16. [Nephrotic syndrome and trimethadione]. VERGER P; SERVILLE F Ann Pediatr (Paris); 1962 Jan; 9():29-31. PubMed ID: 14040017 [No Abstract] [Full Text] [Related]
17. Blood disorders caused by drug sensitivity. CARTWRIGHT GE; WINTROBE MM AMA Arch Intern Med; 1956 Nov; 98(5):559-66. PubMed ID: 13361590 [No Abstract] [Full Text] [Related]
18. [Megaloblastic anemia in anti-epileptic therapy]. LINKE A; HERBERG D Dtsch Med Wochenschr; 1959 Aug; 84():1548-50. PubMed ID: 14417271 [No Abstract] [Full Text] [Related]
19. Disorders of the blood in changing environmental conditions. Rachmilewitz M Hamatol Bluttransfus; 1970; 9():138-48. PubMed ID: 4101214 [No Abstract] [Full Text] [Related]
20. Alopecia as a side effect of treatment of epilepsy with trimethadione. Report of two cases. HOLOWACH J; SANDEN HV N Engl J Med; 1960 Dec; 263():1187. PubMed ID: 13715510 [No Abstract] [Full Text] [Related] [Next] [New Search]